Showing results (41-50 of 55) with videos related to
Sort By:
Pageof 6
The International Journal of Biological Markers|October 1, 1988
Changes in receptor status after treatment with tamoxifen in endometrial cancerS Oriana, F Raspagliesi, P G Duca, et al.Oncology|May 1, 1994
Goserelin in premenopausal advanced breast cancer: clinical and endocrine evaluation of responsive patientsE Bajetta, N Zilembo, R Buzzoni, et al.Tumori|April 30, 1984
Hormonal and receptor status in postmenopausal women with endometrial carcinoma before and after treatment with tamoxifenL Luciani, S Oriana, G Spatti, et al.Journal of Neural Transmission (Vienna, Austria : 1996)|January 9, 2014
Emerging issues on selection criteria of levodopa carbidopa infusion therapy: considerations on outcome of 28 consecutive patientsMariachiara Sensi, F Preda, L Trevisani, et al.International Journal of Oral and Maxillofacial Surgery|April 24, 2017
Comparison between piezoelectric surgery and conventional saw in sagittal split osteotomies: a systematic reviewL F Silva, E N R Carvalho-Reis, J P Bonardi, et al.British Journal of Cancer|July 17, 2003
Vascular endothelial growth factor in node-positive breast cancer patients treated with adjuvant tamoxifenD Coradini, E Biganzoli, C Pellizzaro, et al.British Journal of Cancer|May 1, 1994
The intramuscular administration of granulocyte colony-stimulating factor as an adjunct to chemotherapy in pretreated ovarian cancer patients: an Italian Trials in Medical Oncology (ITMO) Group pilot studyA Di Leo, E Bajetta, F Nolè, et al.European Journal of Cancer (Oxford, England : 1990)|December 1, 1995
An I.T.M.O. group study on second-line treatment in advanced epithelial ovarian cancer: an attempt to identify clinical and biological factors determining prognosisA Di Leo, E Bajetta, L Biganzoli, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 15, 2000
Time-dependent relevance of steroid receptors in breast cancerD Coradini, M G Daidone, P Boracchi, et al.Tumori|December 31, 1994
An intensive treatment with mitoxantrone and ifosfamide in second-line therapy of epithelial ovarian cancerA D Leo, L Biganzoli, S Bohm, et al.Pageof 6